These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pediatric renal transplantation at the University of Minnesota: the cyclosporine years. Chavers BM; Matas AJ; Gillingham KJ; Schmidt WJ; Najarian JS Clin Transpl; 1994; ():203-12. PubMed ID: 7547541 [TBL] [Abstract][Full Text] [Related]
5. Influence of rejection on graft survival after renal transplantation. Lytton B; Finkelstein FO; Schiff M; Black HR Trans Am Assoc Genitourin Surg; 1975; 67():99-102. PubMed ID: 788307 [TBL] [Abstract][Full Text] [Related]
6. Long-term survival and late graft loss in pediatric liver transplant recipients--a 15-year single-center experience. Wallot MA; Mathot M; Janssen M; Hölter T; Paul K; Buts JP; Reding R; Otte JB; Sokal EM Liver Transpl; 2002 Jul; 8(7):615-22. PubMed ID: 12089716 [TBL] [Abstract][Full Text] [Related]
7. The fate of renal transplants in patients with IgA nephropathy. Frohnert PP; Donadio JV; Velosa JA; Holley KE; Sterioff S Clin Transplant; 1997 Apr; 11(2):127-33. PubMed ID: 9113449 [TBL] [Abstract][Full Text] [Related]
8. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091 [TBL] [Abstract][Full Text] [Related]
9. Immunosuppression in live-related donor renal transplantation. Iman A; Rao M; Juneja R; Jacob CK Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322 [TBL] [Abstract][Full Text] [Related]
11. Steroid withdrawal in kidney transplant recipients: is it a safe option? Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950 [TBL] [Abstract][Full Text] [Related]
12. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [TBL] [Abstract][Full Text] [Related]
13. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109 [TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
15. Polyomavirus nephropathy after renal transplantation: a single centre experience. Kim HC; Hwang EA; Han SY; Park SB; Park KK Nephrology (Carlton); 2005 Apr; 10(2):198-203. PubMed ID: 15877682 [TBL] [Abstract][Full Text] [Related]
16. [Pediatric renal transplantation: clinical analysis of 23 cases]. Chen JH; Shen W; He Q; Jiang R; Peng WH Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1100-3. PubMed ID: 15498295 [TBL] [Abstract][Full Text] [Related]